RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/37527040http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/37527040http://www.w3.org/2000/01/rdf-schema#comment"Cyclin-dependent kinase 4 (CDK4) and retinoblastoma protein (RB) are both important cell-cycle regulators that function in different scenarios. Here, we report that FERM domain-containing 8 (FRMD8) inhibits CDK4 activation and stabilizes RB, thereby causing cell-cycle arrest and inhibiting colorectal cancer (CRC) cell growth. FRMD8 interacts separately with CDK7 and CDK4, and it disrupts the interaction of CDK7 with CDK4, subsequently inhibiting CDK4 activation. FRMD8 competes with MDM2 to bind RB and attenuates MDM2-mediated RB degradation. Frmd8 deficiency in mice accelerates azoxymethane/dextran-sodium-sulfate-induced colorectal adenoma formation. The FRMD8 promoter is hypermethylated, and low expression of FRMD8 predicts poor prognosis in CRC patients. Further, we identify an LKCHE-containing FRMD8 peptide that blocks MDM2 binding to RB and stabilizes RB. Combined application of the CDK4 inhibitor and FRMD8 peptide leads to marked suppression of CRC cell growth. Therefore, using an LKCHE-containing peptide to interfere with the MDM2-RB interaction may have therapeutic value in CDK4/6 inhibitor-resistant patients."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.org/dc/terms/identifier"doi:10.1016/j.celrep.2023.112886"xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Gong Y."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Li Q."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Song J."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Sun Y."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Tang Y."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Wang M."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Zhang J."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Wang Z."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Zhang H."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Zhang L."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Wang T."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Wu W."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Yan H."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Yu M."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/author"Zhan J."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/date"2023"xsd:gYear
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/name"Cell Rep"xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/pages"112886"xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/title"FRMD8 targets both CDK4 activation and RB degradation to suppress colon cancer growth."xsd:string
http://purl.uniprot.org/citations/37527040http://purl.uniprot.org/core/volume"42"xsd:string
http://purl.uniprot.org/citations/37527040http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/37527040
http://purl.uniprot.org/citations/37527040http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/37527040